From genes to geometry: Controlling embryo models by programming genomic activation
vol.32 iss.6 (2025) pp.2 On-demand microglia deliver the therapeutic payload in Alzheimer’s disease
vol.32 iss.6 (2025) pp.3 To play Paneth or goblet: Shapeshifting secretory cells read the room
vol.32 iss.6 (2025) pp.3 A new era in regenerative medicine: Cell replacement therapy for Parkinson’s disease is on the horizon
vol.32 iss.6 (2025) pp.3 Breathing new life into donor lungs: Theranostic methodology for organ repair
vol.32 iss.6 (2025) pp.3 Prioritizing human tissue research: Q&A with Danilo Tagle
vol.32 iss.6 (2025) pp.3 Diversifying the reference iPSC line concept
vol.32 iss.6 (2025) pp.5 Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use
vol.32 iss.6 (2025) pp.17 Self-organization of mouse embryonic stem cells into reproducible pre-gastrulation embryo models via CRISPRa programming
vol.32 iss.6 (2025) pp.19 Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins
vol.32 iss.6 (2025) pp.21 An erythroid-biased FOShi hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxia
vol.32 iss.6 (2025) pp.17 Intestinal secretory differentiation reflects niche-driven phenotypic and epigenetic plasticity of a common signal-responsive terminal cell
vol.32 iss.6 (2025) pp.18 Specification of human brain regions with orthogonal gradients of WNT and SHH in organoids reveals patterning variations across cell lines
vol.32 iss.6 (2025) pp.20 HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury
vol.32 iss.6 (2025) pp.16 3D reconstruction of a human Carnegie stage 9 embryo provides a snapshot of early body plan formation
vol.32 iss.6 (2025) pp.19 Vaccination-based immunotherapy to target profibrotic cells in liver and lung
vol.32 iss.6 (2025) pp.2 IRF6 hits the sweet spot
vol.32 iss.5 (2025) pp.2 Signaling switches: Metabolism regulates gastruloid self-organization
vol.32 iss.5 (2025) pp.3 Dopaminergic neurons entering the brain under the immunological cover of darkness
vol.32 iss.5 (2025) pp.3 Shaping intestinal organoids: Engineering crypt curvature to guide stem cell niches
vol.32 iss.5 (2025) pp.3 Roger A. Pedersen (1944–2025)
vol.32 iss.5 (2025) pp.3 Litigation of unlicensed US stem cell products
vol.32 iss.5 (2025) pp.5 Bioengineering innovations for neural organoids with enhanced fidelity and function
vol.32 iss.5 (2025) pp.21 A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models
vol.32 iss.5 (2025) pp.17 m6A deficiency impairs hypothalamic neurogenesis of feeding-related neurons in mice and human organoids and leads to adult obesity in mice
vol.32 iss.5 (2025) pp.17 Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling
vol.32 iss.5 (2025) pp.15 Integrated molecular-phenotypic profiling reveals metabolic control of morphological variation in a stem-cell-based embryo model
vol.32 iss.5 (2025) pp.19 Vagal pathway activation links chronic stress to decline in intestinal stem cell function
vol.32 iss.5 (2025) pp.17 Glucose modulates IRF6 transcription factor dimerization to enable epidermal differentiation
vol.32 iss.5 (2025) pp.16 Human skeletal development and regeneration are shaped by functional diversity of stem cells across skeletal sites
vol.32 iss.5 (2025) pp.13 Vascular network-inspired diffusible scaffolds for engineering functional midbrain organoids
vol.32 iss.5 (2025) pp.14 Bioprinted platform for parallelized screening of engineered microtissues in vivo
vol.32 iss.5 (2025) pp.16 Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity
vol.32 iss.5 (2025) pp.3 The clones have STRACK: Tracing responses to leukemic mutations
vol.32 iss.4 (2025) pp.3 A robust ingredient makes human gut stem cell niches on a dish
vol.32 iss.4 (2025) pp.3 Tonsils weigh in on flu-specific immunity
vol.32 iss.4 (2025) pp.2 Engineered heart tissue patches: A milestone in cardiac regenerative medicine
vol.32 iss.4 (2025) pp.3 A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy
vol.32 iss.4 (2025) pp.5 Progress and challenges in developing allogeneic cell therapies
vol.32 iss.4 (2025) pp.16 Systems immunology analysis of human immune organoids identifies host-specific correlates of protection to different influenza vaccines
vol.32 iss.4 (2025) pp.18 Enhanced viability and functional maturity of iPSC-derived islet organoids by collagen-VI-enriched ECM scaffolds
vol.32 iss.4 (2025) pp.17 Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations
vol.32 iss.4 (2025) pp.17 Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation
vol.32 iss.4 (2025) pp.17 Interferon-responsive intestinal BEST4/CA7+ cells are targets of bacterial diarrheal toxins
vol.32 iss.4 (2025) pp.15 Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin
vol.32 iss.4 (2025) pp.14 Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy
vol.32 iss.4 (2025) pp.18 Overcoming gene dosage barriers in mammalian development: An imprinting balancing act
vol.32 iss.3 (2025) pp.3 PSPC1 bridges cancer stemness and malignancy in acute myeloid leukemia
vol.32 iss.3 (2025) pp.3 Stripe out for brain evolution: Astrocytes go human
vol.32 iss.3 (2025) pp.3 Autologous cells, no longer lost in translation
vol.32 iss.3 (2025) pp.2
vol.32 iss.6 (2025) pp.2 On-demand microglia deliver the therapeutic payload in Alzheimer’s disease
vol.32 iss.6 (2025) pp.3 To play Paneth or goblet: Shapeshifting secretory cells read the room
vol.32 iss.6 (2025) pp.3 A new era in regenerative medicine: Cell replacement therapy for Parkinson’s disease is on the horizon
vol.32 iss.6 (2025) pp.3 Breathing new life into donor lungs: Theranostic methodology for organ repair
vol.32 iss.6 (2025) pp.3 Prioritizing human tissue research: Q&A with Danilo Tagle
vol.32 iss.6 (2025) pp.3 Diversifying the reference iPSC line concept
vol.32 iss.6 (2025) pp.5 Hallmarks of MSCs: Key quality attributes for pharmacology and clinical use
vol.32 iss.6 (2025) pp.17 Self-organization of mouse embryonic stem cells into reproducible pre-gastrulation embryo models via CRISPRa programming
vol.32 iss.6 (2025) pp.19 Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins
vol.32 iss.6 (2025) pp.21 An erythroid-biased FOShi hematopoietic multipotent progenitor subpopulation contributes to adaptation to chronic hypoxia
vol.32 iss.6 (2025) pp.17 Intestinal secretory differentiation reflects niche-driven phenotypic and epigenetic plasticity of a common signal-responsive terminal cell
vol.32 iss.6 (2025) pp.18 Specification of human brain regions with orthogonal gradients of WNT and SHH in organoids reveals patterning variations across cell lines
vol.32 iss.6 (2025) pp.20 HBO1 functions as an epigenetic barrier to hepatocyte plasticity and reprogramming during liver injury
vol.32 iss.6 (2025) pp.16 3D reconstruction of a human Carnegie stage 9 embryo provides a snapshot of early body plan formation
vol.32 iss.6 (2025) pp.19 Vaccination-based immunotherapy to target profibrotic cells in liver and lung
vol.32 iss.6 (2025) pp.2 IRF6 hits the sweet spot
vol.32 iss.5 (2025) pp.2 Signaling switches: Metabolism regulates gastruloid self-organization
vol.32 iss.5 (2025) pp.3 Dopaminergic neurons entering the brain under the immunological cover of darkness
vol.32 iss.5 (2025) pp.3 Shaping intestinal organoids: Engineering crypt curvature to guide stem cell niches
vol.32 iss.5 (2025) pp.3 Roger A. Pedersen (1944–2025)
vol.32 iss.5 (2025) pp.3 Litigation of unlicensed US stem cell products
vol.32 iss.5 (2025) pp.5 Bioengineering innovations for neural organoids with enhanced fidelity and function
vol.32 iss.5 (2025) pp.21 A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models
vol.32 iss.5 (2025) pp.17 m6A deficiency impairs hypothalamic neurogenesis of feeding-related neurons in mice and human organoids and leads to adult obesity in mice
vol.32 iss.5 (2025) pp.17 Glycolytic activity instructs germ layer proportions through regulation of Nodal and Wnt signaling
vol.32 iss.5 (2025) pp.15 Integrated molecular-phenotypic profiling reveals metabolic control of morphological variation in a stem-cell-based embryo model
vol.32 iss.5 (2025) pp.19 Vagal pathway activation links chronic stress to decline in intestinal stem cell function
vol.32 iss.5 (2025) pp.17 Glucose modulates IRF6 transcription factor dimerization to enable epidermal differentiation
vol.32 iss.5 (2025) pp.16 Human skeletal development and regeneration are shaped by functional diversity of stem cells across skeletal sites
vol.32 iss.5 (2025) pp.13 Vascular network-inspired diffusible scaffolds for engineering functional midbrain organoids
vol.32 iss.5 (2025) pp.14 Bioprinted platform for parallelized screening of engineered microtissues in vivo
vol.32 iss.5 (2025) pp.16 Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity
vol.32 iss.5 (2025) pp.3 The clones have STRACK: Tracing responses to leukemic mutations
vol.32 iss.4 (2025) pp.3 A robust ingredient makes human gut stem cell niches on a dish
vol.32 iss.4 (2025) pp.3 Tonsils weigh in on flu-specific immunity
vol.32 iss.4 (2025) pp.2 Engineered heart tissue patches: A milestone in cardiac regenerative medicine
vol.32 iss.4 (2025) pp.3 A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy
vol.32 iss.4 (2025) pp.5 Progress and challenges in developing allogeneic cell therapies
vol.32 iss.4 (2025) pp.16 Systems immunology analysis of human immune organoids identifies host-specific correlates of protection to different influenza vaccines
vol.32 iss.4 (2025) pp.18 Enhanced viability and functional maturity of iPSC-derived islet organoids by collagen-VI-enriched ECM scaffolds
vol.32 iss.4 (2025) pp.17 Pre-existing stem cell heterogeneity dictates clonal responses to the acquisition of leukemic driver mutations
vol.32 iss.4 (2025) pp.17 Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation
vol.32 iss.4 (2025) pp.17 Interferon-responsive intestinal BEST4/CA7+ cells are targets of bacterial diarrheal toxins
vol.32 iss.4 (2025) pp.15 Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin
vol.32 iss.4 (2025) pp.14 Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy
vol.32 iss.4 (2025) pp.18 Overcoming gene dosage barriers in mammalian development: An imprinting balancing act
vol.32 iss.3 (2025) pp.3 PSPC1 bridges cancer stemness and malignancy in acute myeloid leukemia
vol.32 iss.3 (2025) pp.3 Stripe out for brain evolution: Astrocytes go human
vol.32 iss.3 (2025) pp.3 Autologous cells, no longer lost in translation
vol.32 iss.3 (2025) pp.2
